Drug Delivery Business
drugdeliverybusiness.com
Actively hiring
Biotechnology
Hardware
Health Care
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
Drug Delivery Business provides news, editorial and technology coverage of medical technology companies that specialize in transporting and delivering pharmaceutical compounds in the human body.
News
Senseonics sees activist investor take a major stake
Activist investor Sessa Capital has taken a sizeable stake in long-term, implantable CGM company Senseonics (NYSE: SENS), according to an SEC Schedule 13G filed today. The SEC filing lists Sessa directly owning 4,437,532 shares of Senseonics common stock,
Read more
Report
Abbott, Google to deliver glucose insights through artificial intelligence
Abbott (NYSE: ABT) is turning to Google's artificial intelligence expertise to leverage more glucose insights for users of the Abbott Park, Illinois-based life science giant's Lingo biowearable. Under a multiyear agreement announced today, ongoing glucose
Read more
Report
Embecta Q3 results beat analyst expectations
Julia Rock-Torcivia Embecta Corp. (Nasdaq: EMBC) raised its full-year outlook for adjusted earnings per share as third-quarter results beat analyst estimates. The medtech company, a BD spinoff that specializes in insulin delivery, reported last week net i
Read more
Report
ICU Medical Q2 results beat analyst expectations, driven by infusion systems
Julia Rock-Torcivia ICU Medical (Nasdaq: ICUI) reported second quarter results that beat Wall Street expectations, upping its full-year guidance. San Clemente, California-based ICE Medical, which specializes in IV therapy, infusion pumps and closed-system
Read more
Report
Senseonics more than doubles Q2 revenue in post-Ascensia era
The Senseonics Eversense 365 is the world's first one-year CGM. Image courtesy of SenseonicsSenseonics (NYSE:SENS) stock is up more than 26% today after it reported what CEO Tim Goodnow described as the strongest quarter in the implantable, long-term CGM
Read more
Report
Pro access
Upgrade to see all 11 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.